Yayınlar & Eserler

Yayın Ağı
Makaleler 9
Tümü (9)
SCI-E, SSCI, AHCI (9)
SCI-E, SSCI, AHCI, ESCI (9)
Scopus (9)

1. Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

Özyurt N., Alkan A., Gülbağcı B., Seyyar M., Asik E., ŞAHBAZLAR M., et al.
Cancers , cilt.18, sa.14, 2026 (SCI-Expanded, Scopus)

2. Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study

Atas Ipek S., Yaslikaya S., KARA İ. O., KÖŞECİ T., BAYRAM E., Asarkaya E., et al.
Journal of Clinical Medicine , cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)

3. Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

Köylü B., Celayir Ö. M., Muğlu H., Can O., Şen F., Öven B. B., et al.
Cancers , cilt.18, sa.12, 2026 (SCI-Expanded, Scopus)

4. Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group

Tunbekici S., Sahin G., Ön S., Oruc A., Eryılmaz M. K., SAKİN A., et al.
International Journal of Cancer , cilt.158, sa.7, ss.1881-1890, 2026 (SCI-Expanded, Scopus)

5. Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group

Yıldız S., Demir H., Özüdoğru T., Günenç D., Gökdere Z. S., Arvas H., et al.
Journal of Clinical Medicine , cilt.15, sa.6, 2026 (SCI-Expanded, Scopus)

6. Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

KÖKSAL B., Yildirim H. C., GÜVEN D. C., Kose F., Koymen G., Ozdemir O., et al.
Journal of Clinical Medicine , cilt.15, sa.4, 2026 (SCI-Expanded, Scopus) Creative Commons License

7. Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study

Efil S. C., Bilgin B., Bilgetekin I., Helvaci K., Sakalar T., Nayir E., et al.
Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

8. Does FDG PETCT have a predictive value for neoadjuvant chemotherapy response in nonmetastatic breast cancer?

Dogan E., Disli S. Y., AŞIK E., Karacavus S., ÖZDEMİR F.
Irish Journal of Medical Science , cilt.194, sa.1, ss.31-36, 2025 (SCI-Expanded, Scopus)

9. Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung

DUYGULU M. E., AŞIK E., TÜKENMEZ M. A., TEOMAN G., Yildirim A., FİDAN E.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.70, sa.9, 2024 (SCI-Expanded, Scopus)
Metrikler

Yayın

9

Yayın (WoS)

9

Yayın (Scopus)

9

Atıf (WoS)

5

H-İndeks (WoS)

1

Atıf (Scopus)

6

H-İndeks (Scopus)

1

Açık Erişim

1